Literature DB >> 22990144

Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency.

Konstantina Fragaki1, Samira Ait-El-Mkadem, Annabelle Chaussenot, Catherine Gire, Raymond Mengual, Laurent Bonesso, Marie Bénéteau, Jean-Ehrland Ricci, Valérie Desquiret-Dumas, Vincent Procaccio, Agnès Rötig, Véronique Paquis-Flucklinger.   

Abstract

We report two children, born from consanguineous parents, who presented with early-onset refractory epilepsy associated with psychomotor delay, failure to thrive, blindness and deafness. Polarographic and spectrophotometric analyses in fibroblasts and liver revealed a respiratory chain (RC) dysfunction. Surprisingly, we identified a homozygous nonsense mutation in the GM3 synthase gene by using exome sequencing. GM3 synthase catalyzes the formation of GM3 ganglioside from lactosylceramide, which is the first step in the synthesis of complex ganglioside species. Mass spectrometry analysis revealed that the complete absence of GM3 ganglioside and its biosynthetic derivatives was associated with an upregulation of the alternative globoside pathway in fibroblasts. The accumulation of Gb3 and Gb4 globosides likely has a role in RC dysfunction and in the decrease of mitochondrial membrane potential leading to apoptosis, which we observed in fibroblasts. We show for the first time that GM3 synthase deficiency, responsible for early-onset epilepsy syndrome, leads to a secondary RC dysfunction. Our study highlights the role of secondary mitochondrial disorders that can interfere with the diagnosis and the evolution of other metabolic diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22990144      PMCID: PMC3641379          DOI: 10.1038/ejhg.2012.202

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  26 in total

1.  Effects of disialoganglioside GD3 on the mitochondrial membrane potential.

Authors:  Yu Higuchi; Tsuyoshi Miura; Tetsuya Kajimoto; Yoshihiro Ohta
Journal:  FEBS Lett       Date:  2005-06-06       Impact factor: 4.124

Review 2.  Infantile and pediatric quinone deficiency diseases.

Authors:  Agnès Rötig; Julie Mollet; Marlène Rio; Arnold Munnich
Journal:  Mitochondrion       Date:  2007-03-16       Impact factor: 4.160

3.  Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I.

Authors:  J L Dawkins; D J Hulme; S B Brahmbhatt; M Auer-Grumbach; G A Nicholson
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

4.  Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide.

Authors:  T I Gudz; K Y Tserng; C L Hoppel
Journal:  J Biol Chem       Date:  1997-09-26       Impact factor: 5.157

Review 5.  Multi-system disorders of glycosphingolipid and ganglioside metabolism.

Authors:  You-Hai Xu; Sonya Barnes; Ying Sun; Gregory A Grabowski
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

6.  Rapid Profiling of Bovine and Human Milk Gangliosides by Matrix-Assisted Laser Desorption/Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.

Authors:  Hyeyoung Lee; Hyun Joo An; Larry A Lerno; J Bruce German; Carlito B Lebrilla
Journal:  Int J Mass Spectrom       Date:  2011-08-15       Impact factor: 1.986

7.  Epileptic phenotypes associated with mitochondrial disorders.

Authors:  L Canafoglia; S Franceschetti; C Antozzi; F Carrara; L Farina; T Granata; E Lamantea; M Savoiardo; G Uziel; F Villani; M Zeviani; G Avanzini
Journal:  Neurology       Date:  2001-05-22       Impact factor: 9.910

8.  Epileptic phenotypes in children with respiratory chain disorders.

Authors:  Sandra El Sabbagh; Anne-Sophie Lebre; Nadia Bahi-Buisson; Pascale Delonlay; Christine Soufflet; Nathalie Boddaert; Marlène Rio; Agnès Rötig; Olivier Dulac; Arnold Munnich; Isabelle Desguerre
Journal:  Epilepsia       Date:  2010-02-19       Impact factor: 5.864

9.  Dramatic improvement in mitochondrial cardiomyopathy following treatment with idebenone.

Authors:  T Lerman-Sagie; P Rustin; D Lev; M Yanoov; E Leshinsky-Silver; A Sagie; T Ben-Gal; A Munnich
Journal:  J Inherit Metab Dis       Date:  2001-02       Impact factor: 4.982

10.  Mitochondrial respiratory chain defects: underlying etiology in various epileptic conditions.

Authors:  Young Mock Lee; Hoon Chul Kang; Joon Soo Lee; Se Hoon Kim; Eung Yeop Kim; Seung Koo Lee; Abdelhamid Slama; Heung Dong Kim
Journal:  Epilepsia       Date:  2008-02-05       Impact factor: 5.864

View more
  39 in total

1.  A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation.

Authors:  Luigi Boccuto; Kazuhiro Aoki; Heather Flanagan-Steet; Chin-Fu Chen; Xiang Fan; Frank Bartel; Marharyta Petukh; Ayla Pittman; Robert Saul; Alka Chaubey; Emil Alexov; Michael Tiemeyer; Richard Steet; Charles E Schwartz
Journal:  Hum Mol Genet       Date:  2013-09-10       Impact factor: 6.150

Review 2.  Neurological aspects of human glycosylation disorders.

Authors:  Hudson H Freeze; Erik A Eklund; Bobby G Ng; Marc C Patterson
Journal:  Annu Rev Neurosci       Date:  2015-04-02       Impact factor: 12.449

3.  Sialylation regulates brain structure and function.

Authors:  Seung-Wan Yoo; Mary G Motari; Keiichiro Susuki; Jillian Prendergast; Andrea Mountney; Andres Hurtado; Ronald L Schnaar
Journal:  FASEB J       Date:  2015-04-06       Impact factor: 5.191

4.  ST3GAL5-Related Disorders: A Deficiency in Ganglioside Metabolism and a Genetic Cause of Intellectual Disability and Choreoathetosis.

Authors:  Eliza Gordon-Lipkin; Julie S Cohen; Siddharth Srivastava; Bruno P Soares; Eric Levey; Ali Fatemi
Journal:  J Child Neurol       Date:  2018-09-05       Impact factor: 1.987

Review 5.  Application of next-generation sequencing technologies in Neurology.

Authors:  Teng Jiang; Meng-Shan Tan; Lan Tan; Jin-Tai Yu
Journal:  Ann Transl Med       Date:  2014-12

6.  Ganglioside regulation of AMPA receptor trafficking.

Authors:  Jillian Prendergast; George K E Umanah; Seung-Wan Yoo; Olof Lagerlöf; Mary G Motari; Robert N Cole; Richard L Huganir; Ted M Dawson; Valina L Dawson; Ronald L Schnaar
Journal:  J Neurosci       Date:  2014-09-24       Impact factor: 6.167

Review 7.  Human genetic disorders of sphingolipid biosynthesis.

Authors:  Leonardo Astudillo; Frédérique Sabourdy; Nicole Therville; Heiko Bode; Bruno Ségui; Nathalie Andrieu-Abadie; Thorsten Hornemann; Thierry Levade
Journal:  J Inherit Metab Dis       Date:  2014-08-21       Impact factor: 4.982

8.  Glycosphingolipid metabolic reprogramming drives neural differentiation.

Authors:  Domenico Russo; Floriana Della Ragione; Riccardo Rizzo; Eiji Sugiyama; Francesco Scalabrì; Kei Hori; Serena Capasso; Lucia Sticco; Salvatore Fioriniello; Roberto De Gregorio; Ilaria Granata; Mario R Guarracino; Vittorio Maglione; Ludger Johannes; Gian Carlo Bellenchi; Mikio Hoshino; Mitsutoshi Setou; Maurizio D'Esposito; Alberto Luini; Giovanni D'Angelo
Journal:  EMBO J       Date:  2017-12-27       Impact factor: 11.598

Review 9.  The consequences of genetic and pharmacologic reduction in sphingolipid synthesis.

Authors:  Raphael Schiffmann
Journal:  J Inherit Metab Dis       Date:  2014-08-28       Impact factor: 4.982

Review 10.  Gangliosides of the Vertebrate Nervous System.

Authors:  Ronald L Schnaar
Journal:  J Mol Biol       Date:  2016-05-31       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.